<DOC>
	<DOCNO>NCT02263261</DOCNO>
	<brief_summary>Use HADM implant post-mastectomy breast reconstruction .</brief_summary>
	<brief_title>Evaluation Human Acellular Dermal Matrix Post Mastectomy Reconstruction</brief_title>
	<detailed_description>This prospective , single-site pilot study outcomes associate use Flex HD® Pliable™ Perforated , Human Acellular Dermal Matrix implant use post-mastectomy breast reconstruction obtain . The data collect include reconstructive outcome , aesthetic outcome patient-reported outcome order ascertain advantage disadvantage use particular HADM post-mastectomy breast reconstruction .</detailed_description>
	<criteria>Scheduled undergo single twostage , tissueassisted , implant breast reconstruction Mastectomy may unilateral bilateral , prophylactic therapeutic Skin incision may skin sparing , nippleareolar spar Have sign write , inform consent Be least 18 year age Patients undergo autologous breast reconstruction Patients undergoing breast reconstruction follow complication breast augmentation , mastopexy , breast reduction , breast conservation surgery ( lumpectomy ) Patients undergoing reconstruction previously fail attempt reconstruction Patients undergo autologous breast reconstruction conjunction tissue expander ( latissimus dorsi flap , DIEP flap ) There exclusion base race ethnicity BMI &gt; 40 Previous Radiation Treatment . Note : Postoperative radiation treatment exclude subject study continuation enrol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>dermal matrix</keyword>
</DOC>